Volume 14, Issue 1, Pages (July 2011)

Slides:



Advertisements
Similar presentations
Peter L. Lee, Yuefeng Tang, Huawei Li, David A. Guertin 
Advertisements

Volume 14, Issue 6, Pages (December 2011)
Volume 2, Issue 4, Pages (October 2005)
Volume 9, Issue 3, Pages (March 2009)
The Glucocorticoid Receptor Controls Hepatic Dyslipidemia through Hes1
Volume 23, Issue 3, Pages (March 2016)
Volume 23, Issue 3, Pages (March 2016)
Volume 9, Issue 2, Pages (February 2009)
Volume 8, Issue 4, Pages (October 2008)
Volume 15, Issue 4, Pages (April 2012)
Volume 134, Issue 2, Pages (July 2008)
Ling Yang, Ping Li, Suneng Fu, Ediz S. Calay, Gökhan S. Hotamisligil 
Irs1 Serine 307 Promotes Insulin Sensitivity in Mice
Volume 24, Issue 6, Pages (December 2016)
Grzegorz Sumara, Olga Sumara, Jason K. Kim, Gerard Karsenty 
Joseph T. Rodgers, Rutger O. Vogel, Pere Puigserver  Molecular Cell 
Volume 6, Issue 3, Pages (September 2007)
Volume 17, Issue 4, Pages (April 2013)
Volume 7, Issue 4, Pages (April 2008)
Volume 12, Issue 4, Pages (October 2010)
Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene
Volume 2, Issue 2, Pages (August 2005)
Volume 26, Issue 5, Pages e3 (November 2017)
Volume 17, Issue 5, Pages (May 2013)
Volume 23, Issue 4, Pages (April 2016)
Volume 13, Issue 4, Pages (April 2011)
Volume 13, Issue 8, Pages (November 2015)
Volume 24, Issue 3, Pages (September 2016)
Volume 22, Issue 1, Pages (January 2018)
Volume 2, Issue 5, Pages (November 2005)
Jinhan He, Shigeru Nishida, Meishu Xu, Makoto Makishima, Wen Xie 
Volume 93, Issue 5, Pages (May 1998)
Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene
Volume 136, Issue 6, Pages (March 2009)
Volume 16, Issue 4, Pages (October 2012)
Volume 3, Issue 2, Pages (February 2006)
Volume 20, Issue 1, Pages (July 2014)
Volume 21, Issue 5, Pages (May 2015)
Volume 14, Issue 5, Pages (November 2011)
Volume 6, Issue 4, Pages (October 2007)
Volume 10, Issue 5, Pages (November 2009)
Volume 8, Issue 2, Pages (August 2008)
Volume 25, Issue 4, Pages e4 (April 2017)
Volume 5, Issue 5, Pages (May 2007)
Volume 18, Issue 1, Pages (July 2013)
Volume 6, Issue 3, Pages (September 2007)
Volume 13, Issue 1, Pages (January 2011)
Joseph T. Rodgers, Wilhelm Haas, Steven P. Gygi, Pere Puigserver 
Volume 16, Issue 2, Pages (August 2012)
Volume 21, Issue 3, Pages (March 2015)
Volume 23, Issue 3, Pages (March 2016)
Volume 15, Issue 6, Pages (June 2012)
Volume 4, Issue 5, Pages (November 2006)
Volume 13, Issue 4, Pages (April 2011)
PAS Kinase Drives Lipogenesis through SREBP-1 Maturation
Identification of SH2-B as a key regulator of leptin sensitivity, energy balance, and body weight in mice  Decheng Ren, Minghua Li, Chaojun Duan, Liangyou.
Circadian Dysfunction Induces Leptin Resistance in Mice
Xiaoyue Pan, Yuxia Zhang, Li Wang, M. Mahmood Hussain  Cell Metabolism 
Volume 16, Issue 4, Pages (October 2012)
Volume 20, Issue 4, Pages (October 2014)
Cbx4 Sumoylates Prdm16 to Regulate Adipose Tissue Thermogenesis
Volume 26, Issue 5, Pages e3 (November 2017)
Volume 4, Issue 5, Pages (November 2006)
Volume 9, Issue 4, Pages (April 2009)
Adipose Fatty Acid Oxidation Is Required for Thermogenesis and Potentiates Oxidative Stress-Induced Inflammation  Jieun Lee, Jessica M. Ellis, Michael J.
Volume 7, Issue 1, Pages (January 2008)
Volume 24, Issue 6, Pages (December 2016)
The GCN2 eIF2α Kinase Regulates Fatty-Acid Homeostasis in the Liver during Deprivation of an Essential Amino Acid  Feifan Guo, Douglas R. Cavener  Cell.
Brown Adipose Tissue Thermogenic Capacity Is Regulated by Elovl6
Transcriptional Control of Brown Fat Determination by PRDM16
Presentation transcript:

Volume 14, Issue 1, Pages 123-130 (July 2011) Molecular Control of Systemic Bile Acid Homeostasis by the Liver Glucocorticoid Receptor  Adam J. Rose, Mauricio Berriel Díaz, Anja Reimann, Johanna Klement, Tessa Walcher, Anja Krones-Herzig, Oliver Strobel, Jens Werner, Achim Peters, Anna Kleyman, Jan P. Tuckermann, Alexandros Vegiopoulos, Stephan Herzig  Cell Metabolism  Volume 14, Issue 1, Pages 123-130 (July 2011) DOI: 10.1016/j.cmet.2011.04.010 Copyright © 2011 Elsevier Inc. Terms and Conditions

Cell Metabolism 2011 14, 123-130DOI: (10.1016/j.cmet.2011.04.010) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 1 Liver Glucocorticoid Receptor Deficiency Disrupts Systemic Bile Acid Homeostasis (A–F) Serum (A), liver (B), intestine (C), and gallbladder (GB) bile, (D), bile acid (BA) levels in fasted or refed male C57BL/6J mice treated with PBS (n = 4), negative control (NC; n = 8), or GR-specific (n = 8) shRNA adenovirus. Systemic BA distribution was calculated (E). In (F), BA levels in serum samples were collected from individuals with Addison's disease following acute treatment withdrawal as well as matched healthy control individuals before (time 0) and after consuming a nutrient-rich meal (n = 9). (G–J) Serum BA (G), GB BA content (I), and cholesterol saturation index (CSI) (J) in fasted mice on a lithogenic (Lith) or matched control (Con) diet for 14 days. (H) Intact GBs from mice fed Lith diet. (K–R) male C57L/J mice treated with negative control (NC) or GR-specific miRNA adeno-associated virus were placed on a Lith or Con diet for 6 wk (n = 11–12) and analyzed for GB bile acid content (K), volume (L), CSI (O), and serum BA levels (M) in the fasted state. (N) Serum BA levels (N) in wild-type (WT) and hepatocyte-specific GR knockout mice (GRAlfpCre) under normal chow fed conditions (n = 4). (P) representative polarizing light micrographs of GB bile indicative of number of cholesterol crystals per unit volume of bile from same animals as in (K-R). (Q-R) Cholesterol crystals (Q) and gallstones (R) in GB bile in same animals as in (K-R). (S–U) Serum BA (S), GB bile volume (T), and cholesterol crystals (U) in Lith or Con diet-fed C57L/J mice treated daily with Dex (1 mg/kg) or vehicle (Veh) for 14 days (n = 7-8). Data are mean ± SEM. ∗, difference between shRNA/miRNA/genotype; #, difference between treatment; †, interaction between shRNA and diet, p < 0.05. Also see Figure S1. Cell Metabolism 2011 14, 123-130DOI: (10.1016/j.cmet.2011.04.010) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 2 Liver Bile Acid Transport and Slc10a1/Ntcp Expression Are Reduced in Mice with Liver GR Deficiency (A and B) Ex vivo (A, n = 8) and in vitro (B, n = 9) bile acid (BA) uptake/transport in liver samples from mice as in Figure 1. (C–G) Ntcp protein/mRNA expression in livers from mice treated as in Figure 1. Inserts in (C)-(F) are representative western blot images of Ntcp and vasolin-containing protein (Vcp). (H–J) Liver bile acid (BA) uptake (H), serum BA levels (I) and gallbladder bile volume (J) in C57BL/6J mice treated with negative control (NC), low dose (5 × 108 ifu), and normal dose (2 × 109 ifu) Ntcp-specific shRNA adenovirus under fasted or refed conditions (n = 5–6). Data are mean ± SEM. ∗, difference between shRNA/miRNA/genotype/drug versus control; ∗∗, difference between shRNA/miRNA/genotype/drug versus all corresponding groups; # difference between diet, p < 0.05. Also see Figure S2. Cell Metabolism 2011 14, 123-130DOI: (10.1016/j.cmet.2011.04.010) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 3 The DNA-Binding Function of the GR Is Essential for Its Effects on Systemic Bile Acid Homeostasis and Liver Ntcp Expression (A) Avidin-biotin complex DNA (ABCD) assays in mouse liver extracts (n = 3) using glucocorticoid response element (GRE), negative control (neg), and 55 base pair oligonucleotides covering the proximal mouse Ntcp promoter. Insert: representative western blot image. (B and C) Chromatin immunoprecipitation (ChIP) assay of liver extracts from fasted or refed mice using antibodies specific for GR (B, n = 5) and RNA polymerase II (C, n = 8). Precipitated DNA fragments were analyzed using primers flanking the proximal promoter of the mouse Ntcp gene as well as negative control primers (TbpEx3). Data show recruitment relative to negative control IgG and chromatin input. ∗, difference compared with refed; #, difference between shRNA treatment. (D–G) Serum bile acids (BA) (D), gallbladder bile volume (E), liver Ntcp protein expression (F), and maximal BA transport (G) in fasted wild-type (WT) and GR dimerization deficient (GRdim) mice treated daily with dexamethasone (Dex; 1mg/kg) or vehicle (Veh) as well as a lithogenic (Lith) diet for 12 days (n = 3–4). Data are mean ± SEM. ∗, difference between genotype; #, difference between diet; p < 0.05. Also see Figure S3. Cell Metabolism 2011 14, 123-130DOI: (10.1016/j.cmet.2011.04.010) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 4 Extrahepatic Effects of Altered Bile Acid Homeostasis with Liver GR Deficiency (A–C) body mass (A, n = 11–12), fecal triglyceride (B) and nonesterified fatty acid (NEFA, C) levels (n = 6-7) in the same mice as in Figure 1. (D–F) Phospho-Ser/Thr-protein kinase A substrates (D), uncoupling protein 1 (Ucp1, E) and deiodinase-2 (Dio2, F) mRNA levels in brown adipose tissue (BAT) in mice treated as in Figure 1 (n = 5–6). Data are mean ± SEM. ∗, difference between shRNA/miRNA treatment; #, difference between diet; p < 0.05. Also see Figure S4. Cell Metabolism 2011 14, 123-130DOI: (10.1016/j.cmet.2011.04.010) Copyright © 2011 Elsevier Inc. Terms and Conditions